top of page

156-158 PACIFIC HIGHWAY, GREENWICH, NSW 2065

(02) 8061 4048

ABOUT US

The Sydney Brachytherapy Group is a tertiary referral clinic and a certified, licenced and accredited nuclear medicine medical facility at the interventional suites of the North Shore Medical Group. It offers multi-specialist, multidisciplinary healthcare and is a specialist treatment provider of Rhenium-SCT® (skin cancer therapy) for Non-Melanoma Skin Cancers.

 

SBG has specialist medical practitioners onsite and works with accredited visiting medical officers, including nuclear physicians, dermatologists, plastic surgeons, skin cancer surgeons and oncologists, to provide advanced beta-radiation brachytherapy for patients suffering from Basal Cell (BCCs), Squamous Cell Carcinomas (SCCs), Erythroplasia of Queyrat and Bowen’s disease.

Our practice administrators and front-desk staff manage all medical bookings for patients and visiting medical specialists, including billing and administration support.

​

Medical Director Dr. Joseph Gracé chairs the Medical Advisory Committee (MAC) of registered specialist medical practitioners (Visiting Medical Officers or VMOs) who perform treatments at SBG. The VMO specialists include nuclear physicians, dermatologists, plastic surgeons, skin cancer surgeons, and oncologists. All VMOs are accredited by the committee.

 

Find out about becoming a VMO at SBG - enquire here.

SBG Facilities

Sydney Brachytherapy Group is registered with a Radiation Management Licence issued by the Environmental Protection Agency, Australia. The facility boasts the latest in Reflectance Confocal Microscopy and Heine Optotechnik digital dermatoscopy for continued research and development. The clinic is a certified, licenced and accredited nuclear medicine facility performing Rhenium-SCT® (skin cancer therapy) for Non-Melanoma Skin Cancers, Erythroplasia of Queyrat and Bowen’s disease.

 

Primary or secondary referrals for all patients are required from either a general practitioner (GP), specialist skin cancer surgeons or specialist dermatologists.

SBG Logo White+Green.png

ADDRESS

LEVEL 3, SUITE 304,

156-158 PACIFIC HIGHWAY
GREENWICH, NSW
Australia 2065

OPENING HOURS

Monday - Friday: 9:00am – 5:00pm

Treatment Enquiry

Please take a moment to fill out the form.

Thanks for submitting!

REFERENCES: 1. Castellucci P, et al. High dose brachytherapy with non sealed 188Re (rhenium) resin in patients with non-melanoma skin cancers (NMSCs): single center preliminary results. Eur J Nucl Med Mol Imaging. 2021;48(5):1511-1521. doi: 10.1007/s00259-020-05088-z. 2. Cipriani C, et al. Epidermal Radionuclide Therapy - Dermatological High-Dose-Rate. Brachytherapy for the Treatment of Basal and Squamous Cell Carcinoma. In: Therapeutic Nuclear Medicine, editor Baum RP; New York: Springer, 2014. 3. Cipriani C, et al. Personalized irradiation therapy for NMSC by rhenium-188 skin cancer therapy: a long-term retrospective study. J Dermatolog Treat. 2020:1-7. doi: 10.1080/09546634.2020.1793890. 4. Cipriani C, et al. Personalized high-dose-rate brachytherapy with non-sealed rhenium-188 in non-melanoma skin cancer. Int J Nucl Med. 2017;114–112. 5. Data on file. OncoBeta Garching, Germany.

​

Rhenium-SCT® and OncoBeta® is trademark of OncoBeta GmbH.

​

Copyright © 2022. Sydney Brachytherapy Group.

bottom of page